4The ALLHAT officers and coordinators for the ALLHAT collaborative research group. Major Outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) [ J]. JAMA, 2002,288 : 2981-2997.
5Wing LM,Reid CM,Ryan P,et al.For the second Australian national blood pressure study group.A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly[J].N Engl J Med,2003,348:583-592.
6HOPE (Heart Outcomes Prevention Evaluation) study investigators,effects of an angiotensin-converting-enzyme inhibitor,ramipril,on cardiovascular events in high-risk patients[J].N Engl J Med,2000,342:145-153.
7MacMahon S,Sharpe N, Gamble G,et al.Randomised,placebo-controlled trial of the angiotensin converting enzyme inhibitor,ramipril,in patients with coronary or other conclusive vascular disease[J].J Am Coil Cardiol,2000,36:438-443.
8Cashin Hemphill L, Holmvang G,Chan RC,et al.Angiotensin converting enzyme inhibition as antiatherosclerotic therapy: no answer yet[J].Am J Cardiol,1999,83:43-47.
9Teo KK,Burton JR, Buller CE,et al.Long-term effects of cholesterol lowering and angiotensin-converting-enzyme inhibition on coronary atherosclerosis:the simvastatin/enalapril coronary atherosclerosis trial (SCAT) [ J ].Circulation,2000,102:1748-1754.
10PROGRESS Collaborative Group.Randomised trial of a perindopril-based blood pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack[J].Lancet,2001,358:1033-1041.
